Inhibitory effects of lidocaine and mexiletine on vasorelaxation mediated by adenosine triphosphate-sensitive K+ channels and the role of kinases in the porcine coronary artery

Anesthesiology

Volumn 102, Issue 3, 2005, Pages 581-587

  Kimoto, Yoshiki ^a   Kinoshita, Hiroyuki ^a   Nakahata, Katsutoshi ^b   Dojo, Mayuko ^a   Hatano, Yoshio ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ADENOSINE TRIPHOSPHATE; ANTIARRHYTHMIC AGENT; CALPHOSTIN C; ERBSTATIN; ERBSTATIN A; GENISTEIN; GLIBENCLAMIDE; LEMAKALIM; LIDOCAINE; MEXILETINE; PHORBOL 12 ACETATE 13 MYRISTATE; PHOSPHOTRANSFERASE; POTASSIUM CHANNEL; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; HYPERPOLARIZATION; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SWINE; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CORONARY CIRCULATION; CORONARY VESSELS; CROMAKALIM; DOSE-RESPONSE RELATIONSHIP, DRUG; LIDOCAINE; MEMBRANE POTENTIALS; MEXILETINE; POTASSIUM CHANNELS; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; SWINE; VASODILATION;

EID: 14744274644     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200503000-00017     Document Type: Conference Paper

References (43)

1. Quayle JM, Nelson MT, Standen NB: ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 1997; 77:1165-232
2. Ishizaka H, Kuo L: Acidosis-induced coronary arteriolar dilation is mediated by ATP-sensitive potassium channels in vascular smooth muscle. Circ Res 1996; 78:50-7
3. ATP channels and myocardial preconditioning: An update. Am J Physiol 2003; 285:H921-30
4. NDP subtype of vascular smooth muscle ATP-sensitive potassium channel. Circ Res 2000; 87:112-7
5. Farouque HMO, Worthley SG, Meredith IT, Skyrme-Jones RAP, Zhang MJ: Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans. Circ Res 2002; 90:231-6
6. + channels in rabbit portal vein smooth muscle. Br J Pharmacol 1997; 122:1395-404
7. + channel openers in rat aortas. ANESTHESIOLOGY 1999; 90:1165-70
8. 2+ entry pathway in regulation of EDHF in porcine coronary artery. Am J Physiol 2001; 280:H730-7
9. Nagao T, Vanhoutte PM: Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery. J Physiol 1992; 445: 355-67
10. + channel protects against hypertension. J Clin Invest 2004; 113:955-7
11. + channel openers. J Vasc Res 1993; 30:2-12
12. Nelson MT, Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995; 268:C799-822
13. 2+ channel in rat vascular muscle. J Vasc Res 1994; 31:256-64
14. Beech DJ, Zhang H, Nakao K, Bolton TB: Single channel and whole-cell K-currents evoked by levcromakalim in smooth muscle cells from the rabbit portal vein. Br J Pharmacol 1993; 110:583-90
15. Kuriyama H, Kitamura K, Nabata H: Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacological Rev 1995; 47:387-573
16. ATP channels in vascular smooth muscles. Circ Res 2003; 92:1225-32
17. + channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 1998; 507:117-29
18. Hofmann J: The potential for isozyme-selective modulation of protein kinase C. FASEB J 1997; 11:649-69
19. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C: Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 1993; 268:9194-7
20. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Eto Y, Morishige K, Matsumoto Y, Obara K, Nakayama K, Takahashi S, Takeshita A: Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm. Arterioscler Thromb Vasc Biol 2003; 23:2209-14
21. + channel function after brain injury. Stroke 1999; 30:153-9
22. Armstead WM: Vasopressin-induced protein kinase C-dependent superoxide generation contributes to ATP-sensitive potassium channel but not calcium-sensitive potassium channel function impairment after brain injury. Stroke 2001; 32:1408-14
23. Bonev AD, Nelson MT: Vasoconstrictors inhibit ATP-sensitive K+ channels arterial smooth muscle through protein kinase C. J Gen Physiol 1996; 108:315-23
24. + currents in the rat arterial smooth muscle cells through protein kinase C. J Physiol 1997; 503:489-96
25. ATP, channels by inhibiting steady-state protein kinase A activity and activating protein kinase Cε. J Physiol 2001; 530:193-205
26. + channel-mediated responses of the basilar artery. Stroke 2002; 33:1692-7
27. + channel openers. Pharmacol Ther 2000; 85:39-53
28. + channel openers. Mol Pharmacol 1999; 56:308-15
29. + channels composed of Kir6.1 and/or Kir 6.2 expresses with SUR2B. J Physiol 2002; 541:65-80
30. + channels? Circ Res 2003; 93:646-55
31. 2+-independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1999; 96:1123-8
32. 2+-independent mechanism. J Biol Chem 1995; 270:1057-61
33. Umezawa K, Hori T, Tajima H, Imoto M, Isshiki K, Takeuchi T: Inhibition of epidermal growth factor-induced DNA synthesis by tyrosine kinase inhibitors. FEBS Lett 1990; 260:198-200
34. Ca channel cerebrovasodilation. Am J Physiol 2003; 285:R149-54
35. Ca channel impairment after brain injury. Brain Res 2002; 943:276-82
36. Estes NAM III, Manolis AS, Greenblatt DJ, Garan HG, Ruskin JN: Therapeutic serum lidocaine and metabolite concentrations in patients undergoing electrophysiologic study after discontinuation of intravenous lidocaine infusion. Am Heart J 1989; 117:1060-4
37. Talbot RG, Clark RA, Nimmo J, Neilson JMM, Julian DG, Prescott LF: Treatment of ventricular arrhythmias with mexiletine. Lancet 1973; 11:399-404
38. Meunier J-F, Goujard E, Dubousset A-M, Samii K, Mazoit JX: Pharmacokinetics of bupivacaine after continuous epidural infusion in infants with and without biliary atresia. ANESTHESIOLOGY 2001; 95:87-95
39. Winkle RA, Glantz SA, Harrison DC: Pharmacologic therapy of ventricular arrhythmias. Am J Cardiol 1975; 36:629-50
40. Woosley RL, Funck-Brentano C: Overview of the clinical pharmacology of antiarrhythmic drugs. Am J Cardiol 1988; 61:61A-9A
41. ATP-channels. Br J Pharmacol 1997; 120:728-34
42. Gomma AH, Purcell HJ, Fox KM: Potassium channel openers in myocardial ischaemia: Therapeutic potential of nicorandil. Drugs 2001; 61:1705-10
43. The IONA Study Group: Effect of nicorandil on coronary events in patients with stable angina: The impact of nicorandil in angina (IONA) randomised trial. Lancet 2002; 359:1269-75